The efficacy and safety of aflibercept and conbercept in diabetic macular edema

@inproceedings{Cai2018TheEA,
  title={The efficacy and safety of aflibercept and conbercept in diabetic macular edema},
  author={Siwei Cai and Qianhui Yang and Xiaorong Li and Yan Zhang},
  booktitle={Drug design, development and therapy},
  year={2018}
}
Diabetic macular edema (DME) has shown an increasing prevalence during the past years and is the leading cause of diabetic retinopathy blindness. Traditional treatment modalities include laser and corticosteroid therapy, which, however, either act through unclear mechanisms or cause cataracts and elevated intraocular pressure. In recent years, as the pathogenic role of VEGF in DME has been well-recognized, the intravitreal injection of anti-VEGF drugs has become the first-line treatment of DME… CONTINUE READING

From This Paper

Figures, tables, and topics from this paper.

References

Publications referenced by this paper.
SHOWING 1-10 OF 75 REFERENCES

Similar Papers

Loading similar papers…